Evolus Goodwill and Intangible Assets 2016-2025 | EOLS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Evolus goodwill and intangible assets from 2016 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Evolus goodwill and intangible assets from 2016 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$225.2B
Boston Scientific (BSX)	$151.9B
Stryker (SYK)	$144.9B
EssilorLuxottica (ESLOY)	$142.5B
Medtronic (MDT)	$119.1B
Lonza Group Ag (LZAGY)	$48B
Haleon (HLN)	$43.5B
ResMed (RMD)	$42.2B
GE HealthCare Technologies (GEHC)	$34.4B
Agilent Technologies (A)	$34.2B
Terumo (TRUMY)	$27.9B
Koninklijke Philips (PHG)	$26.3B
Insulet (PODD)	$21.7B
Zimmer Biomet Holdings (ZBH)	$20.4B
Smith & Nephew SNATS (SNN)	$16.1B
Baxter (BAX)	$12.4B
Sunny Optical Technology (SNPTF)	$10.8B
Demant (WILYY)	$8.1B
Bio-Rad Laboratories (BIO)	$7.8B
Lantheus Holdings (LNTH)	$3.7B
Envista Holdings (NVST)	$3.6B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Prestige Consumer Healthcare (PBH)	$3.3B
Perrigo (PRGO)	$3.3B
ICU Medical (ICUI)	$2.8B
Haemonetics (HAE)	$2.6B
LeMaitre Vascular (LMAT)	$2.2B
Curaleaf Holdings (CURLF)	$2.1B
Green Thumb Industries (GTBIF)	$1.9B
QuidelOrtho (QDEL)	$1.8B